VPC
VYGR icon

Vestal Point Capital’s Voyager Therapeutics VYGR Stock Holding History

Vestal Point Capital’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Buy
3,002,936
+1,527,936
+104% +$6.02M 0.32% 62
2025
Q4 		$5.8M Hold
1,475,000
– – 0.2% 59
2025
Q3 		$6.89M Hold
1,475,000
– – 0.31% 57
2025
Q2 		$4.59M Buy
1,475,000
+225,582
+18% +$728K 0.24% 53
2025
Q1 		$4.22M Buy
1,249,418
+19,418
+2% +$90.7K 0.3% 46
2024
Q4 		$6.97M Buy
1,230,000
+740,000
+151% +$4.77M 0.41% 49
2024
Q3 		$2.87M Sell
490,000
-110,000
-18% -$800K 0.22% 59
2024
Q2 		$4.75M Hold
600,000
– – 0.35% 45
2024
Q1 		$5.59M Buy
+600,000
New +$5.07M 0.46% 42

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vestal Point Capital's VYGR Position: Q1 2026 in Review

Vestal Point Capital increased its Voyager Therapeutics (VYGR) stake by 104% in Q1 2026, buying an estimated $6.02M and bringing the position to 3,002,936 shares worth $11.6M. The position accounts for 0.32% of the portfolio, ranked #62.

Vestal Point Capital first reported a position in VYGR in Q1 2024 and has held it in 9 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q1 2026.

  • Vestal Point Capital held 3,002,936 shares of Voyager Therapeutics worth $11.6M as of Q1 2026.
  • Vestal Point Capital bought 1,527,936 Voyager Therapeutics shares in Q1 2026, an estimated $6.02M.
  • Voyager Therapeutics made up 0.32% of Vestal Point Capital's portfolio in Q1 2026, its #62 holding.
  • Vestal Point Capital first reported a position in Voyager Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.